on ADOCIA (EPA:ADOC)
ADOCIA Secures €10 Million Fundraising for Growth
ADOCIA, a biopharmaceutical company, announced a fundraiser raising €10 million in gross proceeds through issuing 1,262,626 new shares with attached warrants. CVI Investments, Inc. subscribed to this offer. Settlement and delivery are anticipated on December 8, 2025.
The raised funds will support ADOCIA’s strategic development, extending its cash runway to early 2027. This includes investing in the industrialization of their BioChaperone® technology and innovating through the AdoXLong™ platform.
Approximately 50% of the funds are designated for the development of the AdoXLong™ platform, with 30% for industrial scale processes, and 20% for working capital. The new shares will be listed on Euronext Paris.
CEO Olivier Soula expressed gratitude to CVI Investments for their support, highlighting the capital increase's role in accelerating company growth.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all ADOCIA news